£77.79

Springer Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)

Price data checked 1 day ago

View at Amazon

Price History & Forecast

Last 11 days • 11 data points

Historical
Generating forecast...
£78.01 £77.77 £77.82 £77.87 £77.93 £77.98 £78.03 01 May 2026 03 May 2026 06 May 2026 08 May 2026 11 May 2026

Price Distribution

Price distribution over 11 days • 1 price levels

Days at Price
11 days 0 3 6 8 11 £78 Days at Price

Price Analysis

Most common price: £78 (11 days, 100.0%)

Price range: £78 - £78

Price levels: 1 different prices over 11 days

Description

Product Description Cellular transformation and carcinogenesis are considered a multistep process starting with DNA lesions and progressing through loss of cellular growth control and increase invasive and metastatic properties. This book focuses on the demonstration of important steps in carcinogenesis, ranging from chemical interaction of carcinogens with cellular DNA in experimental tumors and cell lines to the analysis of selected human tumors. Special importance is given to the clarification of mechanisms of DNA lesions caused by chemical carcinogens and UV irradiation. Leading scientists describe in review articles the actual state of the art in their specific fields. The reader is informed of trends and scientific approaches to the recognition of pathogenetic mechanisms and factors in malignant tumors. From the Back Cover The principal goal of experimental carcinogenesis is the elucidation of mechanisms and factors that might be of relevance for the formation of human tumors. Specialization, as necessary as it may be, however, may prevent the transfer of knowledge among disciplines involved in cancer research. Leading scientists give insight into mechanisms of carcinogen-induced DNA damage and mutagenicity, and cellular responses including DNA repair, cellular stress, apoptosis, and regulation of cellular growth. Selected human tumor models of oral epithelium, skin cancer, and malignant lymphoma are analyzed in order to determine the most relevant primary genetic alteration in cell-specific transformation. Finally, the epidemiology of p53 mutation is considered as an indication of specific pathogenetic factors in sporadic human tumors.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
21 January 2012
Listed Since
13 July 2012

Barcode

No barcode data available

Similar Products You Might Like

Cell Signaling & Molecular Targets in Cancer
84% match

Cell Signaling & Molecular Targets in Cancer

Springer

£107.98 04 May 2026
Cell Signaling & Molecular Targets in Cancer
82% match

Cell Signaling & Molecular Targets in Cancer

Springer

£43.99 04 May 2026
Frontiers in Cancer Research: Evolutionary Foundations, Revolutionary Directions
81% match

Frontiers in Cancer Research: Evolutionary Foundations, Revolutionary Directions

Springer

£112.41 04 May 2026
Neuroendocrine and Oral Cancers: An Interdisciplinary Approach: 14 (Interdisciplinary Cancer Research, 14)
80% match

Neuroendocrine and Oral Cancers: An Interdisciplinary Approach: 14 (Interdisciplinary Cancer Research, 14)

Springer

£141.08 04 May 2026
Genetic Instability and Tumorigenesis: 221 (Current Topics in Microbiology and Immunology, 221)
80% match

Genetic Instability and Tumorigenesis: 221 (Current Topics in Microbiology and Immunology, 221)

Springer

£72.98 11 May 2026
Targeting the DNA Damage Response for Cancer Therapy: 186 (Cancer Treatment and Research, 186)
80% match

Targeting the DNA Damage Response for Cancer Therapy: 186 (Cancer Treatment and Research, 186)

Springer

£73.10 04 May 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
79% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£65.70 04 May 2026
Targeting Lysine Demethylases in Cancer and Other Human Diseases: 1433 (Advances in Experimental Medicine and Biology, 1433)
79% match

Targeting Lysine Demethylases in Cancer and Other Human Diseases: 1433 (Advances in Experimental Medicine and Biology, 1433)

Springer

£100.08 04 May 2026
MicroRNAs in Cancer Translational Research
79% match

MicroRNAs in Cancer Translational Research

Springer

£129.92 10 May 2026
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)
79% match

Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)

Springer

£71.91 04 May 2026
Modification of Radiation Response: Cytokines, Growth Factors and Other Biological Targets (Medical Radiology / Diagnostic Imaging)
79% match

Modification of Radiation Response: Cytokines, Growth Factors and Other Biological Targets (Medical Radiology / Diagnostic Imaging)

Springer

£53.53 04 May 2026
Clinical Ophthalmic Oncology: Retinoblastoma
79% match

Clinical Ophthalmic Oncology: Retinoblastoma

Springer

£70.21 04 May 2026
A Quick Guide to Cancer Epidemiology (SpringerBriefs in Cancer Research)
79% match

A Quick Guide to Cancer Epidemiology (SpringerBriefs in Cancer Research)

Springer

£47.16 04 May 2026
Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)
79% match

Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)

Springer

£104.18 04 May 2026
Practical Oncologic Molecular Pathology: Frequently Asked Questions (Practical Anatomic Pathology)
79% match

Practical Oncologic Molecular Pathology: Frequently Asked Questions (Practical Anatomic Pathology)

Springer

£111.22 10 May 2026
Cancer Immunology and Genetics: An Interdisciplinary Approach: 23 (Interdisciplinary Cancer Research, 23)
79% match

Cancer Immunology and Genetics: An Interdisciplinary Approach: 23 (Interdisciplinary Cancer Research, 23)

Springer

£155.09 10 May 2026
MicroRNAs: Role in Cancer Progression, Diagnostics and Therapy (Advances in Biochemistry in Health and Disease, 34)
79% match

MicroRNAs: Role in Cancer Progression, Diagnostics and Therapy (Advances in Biochemistry in Health and Disease, 34)

Springer

£147.11 04 May 2026
Brain Tumors: An Interdisciplinary Approach: 13 (Interdisciplinary Cancer Research, 13)
79% match

Brain Tumors: An Interdisciplinary Approach: 13 (Interdisciplinary Cancer Research, 13)

Springer

£155.50 10 May 2026
Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)
79% match

Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)

Springer

£127.59 04 May 2026
Retinoids in Oncology (ESO Monographs)
78% match

Retinoids in Oncology (ESO Monographs)

Springer

£113.93 04 May 2026
Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer (Comprehensive Gynecology and Obstetrics)
78% match

Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer (Comprehensive Gynecology and Obstetrics)

Springer

£71.08 04 May 2026
The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)
78% match

The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)

Springer

£40.29 04 May 2026
Breast Cancer Pathophysiology: An Interdisciplinary Approach: 5 (Interdisciplinary Cancer Research, 5)
78% match

Breast Cancer Pathophysiology: An Interdisciplinary Approach: 5 (Interdisciplinary Cancer Research, 5)

Springer

£154.66 04 May 2026
Current Problems in the Epidemiology of Cancer and Lymphomas: Symposium of the "Gesellschaft zur Bekämpfung der Krebskrankheiten Nordrhein-Westfalen ... 39 (Recent Results in Cancer Research, 39)
78% match

Current Problems in the Epidemiology of Cancer and Lymphomas: Symposium of the "Gesellschaft zur Bekämpfung der Krebskrankheiten Nordrhein-Westfalen ... 39 (Recent Results in Cancer Research, 39)

Springer

£74.60 04 May 2026